Dr. Soloman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9520 W Palm Ln
Ste 220
Phoenix, AZ 85037Phone+1 480-443-8400Fax+1 480-443-8697
Summary
- betterdoctor.com/nehad-soloman-md
Education & Training
NYU Grossman Long Island School of MedicineFellowship, Rheumatology, 2002 - 2004- NYU Grossman Long Island School of MedicineResidency, Internal Medicine, 1999 - 2002
Stony Brook University Health Sciences Center School of MedicineClass of 1999
Certifications & Licensure
FL State Medical License 2003 - 2026
AZ State Medical License 2003 - 2025- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Intergy EHR, Vitera Healthcare Solutions, LLC, 2013
- CMS Meaningful Use Stage 1 Certification Acumen nEHR, Health IT Services Group, 2012
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus Start of enrollment: 2022 Mar 07
Roles: Principal Investigator
Publications & Presentations
PubMed
- 4 citationsExpert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.John K Botson, Herbert S B Baraf, Robert T Keenan, John Albert, Karim R Masri
Current Rheumatology Reports. 2022-01-01 - 5 citationsBehçet's ulcerations in the lower extremity: A case reportSeth N. Clark, Anna L. Hronek, Nan E. Hodge, Nehad Soloman, Teri L. Vaughn
Foot. 2015-09-01 - Real-World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line Tumor Necrosis Factor Inhibitor Therapy in the United States.Colin Edgerton, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Jasvinder A Singh
ACR Open Rheumatology. 2024-04-01
Press Mentions
Can a Blood-Based Test Predict TNFi Nonresponse in RA?August 17th, 2021- Rheumatologist and Lawyer Team up to Explain Salary Models and NegotiationNovember 22nd, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
